By Josh Beckerman

Shares of Biocept Inc., which provides liquid biopsy tests for cancer patients, rose 12% to 40 cents after hours as the company said it will conduct Covid-19 testing.

Biocept said it has verified a molecular diagnostic test, and plans to begin accepting physician-ordered testing requests for processing beginning April 15.

Biocept's lab will use Thermo Fisher Scientific Inc.'s TaqPath platform and kit.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

April 09, 2020 20:02 ET (00:02 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Thermo Fisher Scientific Charts.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Thermo Fisher Scientific Charts.